IQV
IQVIA Holdings Inc. · Healthcare · Medical - Diagnostics & Research
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 393.01K | $104.01M | n/a | n/a |
| Q2 2026 | 164 | +9 | 122.10M | $23.56B | +12 | −4 |
| Q1 2026 | 159 | -11 | 122.65M | $21.04B | +3 | −15 |
| Q4 2025 | 169 | +1 | 132.77M | $29.93B | +3 | −1 |
| Q3 2025 | 26 | -1 | 77.42M | $14.69B | +1 | −3 |
| Q2 2025 | 25 | +2 | 68.72M | $10.83B | +2 | n/a |
| Q1 2025 | 20 | -1 | 30.89M | $5.44B | n/a | −1 |
| Q4 2024 | 21 | +1 | 31.11M | $6.11B | +1 | n/a |
| Q3 2024 | 19 | -1 | 19.49M | $4.61B | +1 | −2 |
| Q2 2024 | 20 | n/a | 21.58M | $4.56B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Harris Associates (Oakmark) ✦ | 10.67M | n/a | $2.26B | 3.8% | n/c | 1 | SEC ↗ ×2 |
| 2 | Geode Capital Management ✦ (pasif) | 4.22M | n/a | $890.27M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 1.62M | n/a | $343.42M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 4 | Norges Bank ✦ (pasif) | 1.62M | n/a | $342.81M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Capital World Investors ✦ | 665.93K | n/a | $140.80M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 579.82K | n/a | $122.60M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 333.95K | n/a | $70.61M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | PRIMECAP Management ✦ | 325.18K | n/a | $68.76M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 323.91K | n/a | $68.49M | 0.2% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 313.09K | n/a | $66.20M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 11 | D. E. Shaw & Co. ✦ | 268.55K | n/a | $56.78M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 12 | Adage Capital Partners ✦ | 168.80K | n/a | $35.69M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 131.30K | n/a | $27.76M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 90.69K | n/a | $19.18M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 15 | Marshall Wace ✦ | 77.61K | n/a | $16.41M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 16 | Duquesne Family Office ✦ | 60.36K | n/a | $12.76M | 0.5% | n/c | 1 | SEC ↗ |
| 17 | Markel Group ✦ | 58.73K | n/a | $12.42M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 32.76K | n/a | $6.93M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Fisher Asset Management ✦ | 7.06K | n/a | $1.49M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Bridgewater Associates ✦ | 968 | n/a | $204,674 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1,061 pemegang, 150.48M saham, $24.99B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 2.67K lbr · $697,228
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi